Happel David - Insider Non-Derivative Transactions at Sagimet Biosciences Inc. (SGMT) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 26, 2024, Happel David's relationship to Sagimet Biosciences Inc. (SGMT) is Director,Officer (President & CEO), and currently has 639,200 shares of Series A Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SGMT insiders.
Data Source: SEC.
Happel David - Insider Non-Derivative Transactions of SGMT Series A Common Stock
Happel David - Insider Non-Derivative Transactions at SGMT
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 27, 2024 | P -- (Series A Common Stock) | 12100 | 5.27 | 639200 |
| Dec 8, 2023 | P -- (Series A Common Stock) | 1600 | 4.1 | 627100 |
| Nov 18, 2023 | Acquisition -- (Series A Common Stock) | 624910 | 0 | 625500 |
| Nov 17, 2023 | P -- (Series A Common Stock) | 590 | 2.35 | 590 |